Apellis Pharmaceuticals, Inc. - stock earnings
APLS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -88.6 million USD | 146.4 million USD |
| 2023Q3 | -140.2 million USD | 99.2 million USD |
| 2023Q2 | -122.0 million USD | 95.0 million USD |
| 2023Q1 | -177.8 million USD | 44.8 million USD |
| 2022Q4 | -166.0 million USD | 22.7 million USD |
| 2022Q3 | -191.3 million USD | 22.1 million USD |
| 2022Q2 | -156.0 million USD | 16.3 million USD |
| 2022Q1 | -138.9 million USD | 14.4 million USD |
| 2021Q4 | -147.9 million USD | 60.3 million USD |
| 2021Q3 | -195.6 million USD | 5.7 million USD |
| 2021Q2 | -219.2 million USD | 623000 USD |
| 2021Q1 | -183.7 million USD | ? USD |
| 2020Q4 | 78.3 million USD | 250.0 million USD |
| 2020Q3 | -135.7 million USD | 646000 USD |
| 2020Q2 | -118.6 million USD | ? USD |
| 2020Q1 | -168.8 million USD | ? USD |
| 2019Q4 | -113.2 million USD | -142150 USD |
| 2019Q3 | -69.8 million USD | ? USD |
| 2019Q2 | -71.1 million USD | ? USD |
| 2019Q1 | -50.6 million USD | ? USD |
| 2018Q4 | -36.5 million USD | 11542 USD |
| 2018Q3 | -36.0 million USD | ? USD |
| 2018Q2 | -33.3 million USD | ? USD |
| 2018Q1 | -21.7 million USD | ? USD |
| 2017Q4 | -18.3 million USD | 11542 USD |
| 2017Q3 | -11.6 million USD | ? USD |
| 2017Q2 | -12.1 million USD | ? USD |
| 2017Q1 | -9.1 million USD | ? USD |
| 2016Q4 | -6.6 million USD | ? USD |
| 2016Q3 | -7.2 million USD | ? USD |
| 2015Q4 | -8.2 million USD | ? USD |
| 2015Q3 | -31.2 million USD | ? USD |
| 2014Q4 | -2.7 million USD | ? USD |
| 2014Q3 | -2.5 million USD | ? USD |
APLS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -528.6 million USD | 396.6 million USD |
| 2022 | -652.2 million USD | 75.4 million USD |
| 2021 | -746.4 million USD | 66.6 million USD |
| 2020 | -344.9 million USD | 250.6 million USD |
| 2019 | -309.8 million USD | ? USD |
| 2018 | -127.5 million USD | ? USD |
| 2017 | -51.0 million USD | ? USD |
| 2016 | -27.1 million USD | ? USD |
| 2015 | -46.5 million USD | ? USD |
| 2014 | -10.8 million USD | ? USD |
| 2013 | -4.0 million USD | ? USD |
APLS
Price: $47.28
52 week price:
Earnings Per Share: -4.45 USD
P/E Ratio: -12.87
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.2 million
Ebitda: -11.6 millionMarket Capitalization: 6.9 billion